PRAGUE-17: LAA Closure Holds Up Against DOACs Out to 4 Years
Extended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with
Read moreExtended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with
Read morePhysical activity, long recommended by health experts to reduce risk for obesity, how many cycles of clomid before ivf heart
Read moreIn patients with intermediate risk of atherosclerotic cardiovascular disease along with risk-enhancing factors, coronary artery calcium scoring may help more
Read moreMidlife changes in wealth may affect a patient’s risk of cardiovascular disease, a new cohort study suggests. It found that
Read moreThe optimal first step to address mild to moderately elevated blood pressure and cholesterol in otherwise healthy adults is a
Read moreTaking more steps each day, in short spurts or longer bouts, was associated with a longer life in women older
Read moreTransradial vascular access is often preferred over the transfemoral route in percutaneous coronary intervention (PCI) for its lower associated risks
Read moreFor most vitamin and mineral supplements, there is not enough evidence to recommend for or against taking them to prevent
Read moreRisk factors for cardiovascular disease (CVD) are strongly associated with global cognitive impairment in patients with schizophrenia in new findings
Read morePlans for in-person sessions at the American College of Cardiology (ACC) 2021 Scientific Session (ACC.21) have been scrapped. Organizers had
Read more